Subscribe to RSS
DOI: 10.1055/s-2005-869858
An Efficient Synthesis of Substituted Hydrazides
Publication History
Publication Date:
07 June 2005 (online)
Abstract
Routes for the selective synthesis of 1-, or 2-substituted hydrazides, and 1,2-disubstituted hydrazides are reported. These routes proceed via cyanoborohydride reduction of stable acyl hydrazone intermediates.
Key words
aminations - reductions - hydrazones - condensation - regioselectivity
-
1a
Stieber F.Grether U.Waldmann H. Chem.-Eur. J. 2003, 9: 3270 -
1b
Kraatz U,Kraemer W,Adersch W,Turberg A, andMencke N. inventors; Patent DE19530079. -
1c
Skoda-Földes R.Szarka Z.Kollár L.Dinya Z.Horváth J.Tuba Z. J. Org. Chem. 1999, 64: 2134 -
1d
Kücükgüzel SG.Rollas S.Kücükgüzel I.Kiraz M. Eur. J. Med. Chem. 1999, 34: 1093 - 2
Licandro E.Perdicchia D. Eur. J. Org. Chem. 2004, 665 -
3a
Peet NP.Sunder S.Cregge RJ. J. Org. Chem. 1976, 41: 2733 -
3b
Hinman RL.Fulton D. J. Am. Chem. Soc. 1958, 80: 1895 -
3c
Condon FE. J. Org. Chem. 1972, 37: 3608 -
4a
Wolter M.Klapars A.Buchwald SL. Org. Lett. 2001, 3: 3803 -
4b
Brosse N.Pinto M.-F.Jamart-Grégoire B. J. Org. Chem. 2000, 63: 4370 -
4c
Khatib AA.Sisler HH. Inorg. Chem. 1990, 29: 309 -
6a
Perdicchia D.Licandro E.Maiorana S.Baldolib C.Giannini C. Tetrahedron 2003, 59: 7733 -
6b
Condon FE. J. Org. Chem. 1972, 37: 3615 -
7a
Gomez S.Peters JA.Maschmeyer T. Adv. Synth. Catal. 2002, 344: 1037 -
7b
Kobayashi S.Ishitani H. Chem. Rev. 1999, 99: 1069 -
7c
Gribble GW. Chem. Soc. Rev. 1998, 27: 395 -
9a
Pomerantz M.Bittner S.Khader SB. J. Org. Chem. 1982, 47: 2217 -
9b
Diel PJ.Maier L. Phosphorus Sulfur Relat. Elem. 1988, 36: 85 -
10a
Neighbours DW.Foster AL.Clark SM.Miller JE.Bailey JR. J. Am. Chem. Soc. 1922, 44: 1557 -
10b
Taipele K.Smirnow I. Chem. Ber. 1923, 56: 1794 -
10c
Nilsson JW.Kvarnström I.Musil D.Nilsson I.Samulesson B. J. Med. Chem. 2003, 46: 3985 -
10d
Cavill JL.Peters J.-U.Tomkinson NCO. Chem. Commun. 2003, 728 - 11
Fox HH. J. Org. Chem. 1958, 23: 468 - For recent examples of the use of the use of 2-tert-butylhydrazides, see:
-
14a
Wang Q.Li Z.Huang R.Cheng J. Heteroat. Chem. 2001, 12: 68 -
14b
Nakagawa Y.Hattori K.Minakuchi C.Kugimiya S.Ueno T. Steroids 2000, 65: 117 -
14c
Mohammed-Ali AM.Chan T.-H.Thomas AW.Strunz GM.Jewett B. Can. J. Chem. 1995, 73: 550 - 15
Zhang X.Breslav M.Grimm J.Guan K.Huang A.Liu F.Maryanoff CA.Palmer D.Patel M.Qian Y.Shaw C.Sorgi K.Stefanick S.Xu D. J. Org. Chem. 2002, 67: 9471
References
All compounds gave spectroscopic data in agreement with the assigned structures.
8Data for acyl hydrazone 4c: 1H NMR (250 MHz, CDCl3): δ = 7.55 (2 H, d, J = 8.0 Hz, ArH), 7.25 (2 H, d, J = 8.0 Hz, ArH), 6.45 (1 H, d, J = 10.6 Hz, N=CH a Hb), 6.25 (1 H, d, J = 10.6 Hz, N=CHa H b ), 3.41 [3 H, s, (CO)NCH 3], 2.39 (3 H, s, ArCH 3). 13C NMR (63 MHz, CDCl3): δ = 171.29, 140.45, 131.81, 129.34 (2 C), 128.92, 128.07 (2 C), 27.53, 21.31. MS (ESI+): m/z = 177 [M + H]+.
12Data for acyl hydrazone 7c: 1H NMR (250 MHz, CDCl3): δ = 8.79 [1 H, br s, C(O)NH], 7.65 (2 H, d, J = 8.1 Hz, ArH), 7.25 (2 H, d, J = 8.1 Hz, ArH), 2.35 (3 H, s, ArCH 3), 2.12 (3 H, s, CCH 3), 1.93 (3 H, s, CCH 3). 13C NMR (63 MHz, CDCl3): δ = 163.6, 155.6, 142.0, 130.5, 129.0 (2 C), 127.0 (2 C), 25.3, 21.3, 16.4. MS (ESI+): m/z = 191 [M + H]+.
13Data for 2-isopropyl hydrazides:
Compound 8a: 1H NMR (250 MHz, CDCl3): δ = 7.54 (5 H, m, ArH), 3.26 [1 H, sept, J = 6.3 Hz, CH(CH3)2], 1.13 [6 H, d, J = 6.3 Hz, CH(CH
3)2]. 13C NMR (63 MHz, CDCl3): δ = 167.3, 132.8, 131.7, 128.6 (2 C), 126.7 (2 C), 51.2, 20.7 (2 C). MS (ESI+): m/z = 179 [M + H]+.
Compound 8b: 1H NMR (250 MHz, CDCl3): δ = 7.74 (2 H, d, J = 8.8 Hz, ArH), 6.93 (2 H, d, J = 8.8 Hz, ArH), 3.85 (3 H, s, ArOCH
3), 3.20 [1 H, sept, J = 6.3 Hz, CH(CH3)2], 1.11 [6 H, d, J = 6.3 Hz, CH(CH
3)2]. 13C NMR (63 MHz, CDCl3): δ = 166.9, 162.3, 128.5 (2 C), 125.0, 113.7 (2 C), 55.3, 51.2, 20.7 (2 C). MS (ESI+): m/z = 231 [M + Na]+.
Compound 8c: 1H NMR (250 MHz, CDCl3): δ = 8.63 [1 H, s, C(O)NH], 7.65 (2 H, d, J = 8.1 Hz, ArH), 7.21 (2 H, d, J = 8.1 Hz, ArH), 4.83 (1 H, NHNH), 3.23 [1 H, sept, J = 6.4 Hz, CH(CH3)2], 2.37 (3 H, s, ArCH
3), 1.08 [6 H, d, J = 6.4 Hz, CH(CH
3)2]. 13C NMR (63 MHz, CDCl3): δ = 167.3, 142.2, 129.9, 129.2 (2 C), 126.7 (2 C), 51.2, 21.3, 20.7 (2 C). MS (ESI+): m/z = 193 [M + H]+.
Compound 8d:
1H NMR (250 MHz, CDCl3): δ = 7.64 (2 H, d, J = 8.6 Hz, ArH), 7.36 (2 H, d, J = 8.6 Hz, ArH), 3.17 [1 H, sept, J = 6.3 Hz, CH(CH3)2], 1.05 [6 H, d, J = 6.3 Hz, CH(CH
3)2]. 13C NMR (63 MHz, CDCl3): δ = 166.3, 137.9, 131.1, 128.8 (2 C), 128.2 (2 C), 51.2, 20.7 (2 C). MS (ESI+): m/z = 213 [35M + H]+, 215 [37M + H]+.
Compound 8e:
1H NMR (360 MHz, CDCl3): δ = 8.29 (2 H, d, J = 8.9 Hz, ArH), 7.95 (2 H, d, J = 8.9 Hz, ArH), 3.25 [1 H, sept, J = 6.3 Hz, CH(CH3)2], 1.11 [6 H, d, J = 6.3 Hz, CH(CH
3)2]. 13C NMR (90 MHz, CDCl3): δ = 165.2, 149.6, 138.3, 128.0 (2 C), 123.8 (2 C), 51.4, 20.7 (2 C). MS (ESI+): m/z = 224 [M + H]+.